Latest Insider Transactions at Artivion, Inc. (AORT)
This section provides a real-time view of insider transactions for Artivion, Inc. (AORT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ARTIVION, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ARTIVION, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 08
2022
|
Rochelle L. Maney VP, Quality |
BUY
Grant, award, or other acquisition
|
Direct |
11,831
+33.07%
|
-
|
|
Nov 08
2022
|
Elizabeth A Hoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,066
+50.0%
|
-
|
|
Nov 08
2022
|
James P Mackin President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
116,954
+19.06%
|
-
|
|
Nov 08
2022
|
Jean F Holloway SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
22,439
+15.36%
|
-
|
|
Nov 08
2022
|
David Ashley Lee Executive VP, COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
36,718
+10.0%
|
-
|
|
Nov 08
2022
|
John E Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,303
+16.85%
|
-
|
|
Nov 08
2022
|
Matthew A Getz VP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
13,191
+29.25%
|
-
|
|
Nov 08
2022
|
Andrew M Green VP Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
12,511
+39.92%
|
-
|
|
Nov 08
2022
|
Dennis B Maier SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
19,447
+31.52%
|
-
|
|
Nov 04
2022
|
Rochelle L. Maney VP, Quality |
SELL
Payment of exercise price or tax liability
|
Direct |
214
-1.74%
|
$2,354
$11.18 P/Share
|
|
Aug 16
2022
|
Rochelle L. Maney VP, Quality |
SELL
Open market or private sale
|
Direct |
7,161
-36.75%
|
$157,542
$22.96 P/Share
|
|
Aug 09
2022
|
Dennis B Maier SVP, Operations |
SELL
Open market or private sale
|
Direct |
5,762
-4.3%
|
$121,002
$21.62 P/Share
|
|
Jun 01
2022
|
Thomas F Ackerman Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,878
+5.82%
|
$149,682
$19.04 P/Share
|
|
Jun 01
2022
|
Daniel J Bevevino Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,878
+5.81%
|
$149,682
$19.04 P/Share
|
|
Jun 01
2022
|
Marna P Borgstrom Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,878
+22.74%
|
$149,682
$19.04 P/Share
|
|
Jun 01
2022
|
James Bullock Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,878
+14.53%
|
$149,682
$19.04 P/Share
|
|
Jun 01
2022
|
Jeffrey H Burbank Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,878
+20.02%
|
$149,682
$19.04 P/Share
|
|
Jun 01
2022
|
Jon W Salveson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,878
+6.83%
|
$149,682
$19.04 P/Share
|
|
Jun 01
2022
|
Anthony B. Semedo Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,878
+22.04%
|
$149,682
$19.04 P/Share
|
|
Mar 08
2022
|
Franz Peter Barthold VP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
76
-0.38%
|
$1,520
$20.32 P/Share
|
|
Mar 08
2022
|
Rochelle L. Maney VP, Quality |
SELL
Payment of exercise price or tax liability
|
Direct |
81
-0.41%
|
$1,620
$20.32 P/Share
|
|
Mar 05
2022
|
Franz Peter Barthold VP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
602
-1.46%
|
$12,642
$21.69 P/Share
|
|
Mar 05
2022
|
John E Davis Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,799
-1.01%
|
$37,779
$21.69 P/Share
|
|
Mar 05
2022
|
Jean F Holloway SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,799
-0.88%
|
$37,779
$21.69 P/Share
|
|
Mar 05
2022
|
Amy Horton VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,132
-0.6%
|
$23,772
$21.69 P/Share
|
|
Mar 05
2022
|
David Ashley Lee Executive VP, COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,146
-0.36%
|
$45,066
$21.69 P/Share
|
|
Mar 05
2022
|
James P Mackin President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,029
-1.67%
|
$273,609
$21.69 P/Share
|
|
Mar 05
2022
|
Dennis B Maier SVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,090
-1.85%
|
$22,890
$21.69 P/Share
|
|
Feb 27
2022
|
Rochelle L. Maney VP, Quality |
SELL
Payment of exercise price or tax liability
|
Direct |
398
-1.99%
|
$7,562
$19.35 P/Share
|
|
Feb 23
2022
|
Andrew M Green VP Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
5,269
+45.47%
|
-
|
|
Feb 23
2022
|
Franz Peter Barthold VP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
4,790
+18.8%
|
-
|
|
Feb 23
2022
|
John E Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,623
+8.78%
|
-
|
|
Feb 23
2022
|
Matthew A Getz VP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
4,790
+20.38%
|
-
|
|
Feb 23
2022
|
Jean F Holloway SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
8,767
+7.84%
|
-
|
|
Feb 23
2022
|
Amy Horton VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,790
+4.83%
|
-
|
|
Feb 23
2022
|
David Ashley Lee Executive VP, COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
11,437
+3.72%
|
-
|
|
Feb 23
2022
|
James P Mackin President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
47,627
+10.82%
|
-
|
|
Feb 23
2022
|
Dennis B Maier SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
7,140
+19.4%
|
-
|
|
Feb 23
2022
|
Rochelle L. Maney VP, Quality |
BUY
Grant, award, or other acquisition
|
Direct |
4,790
+19.35%
|
-
|
|
Feb 23
2022
|
Marshall S. Stanton SVP, Clinical & MD Affair |
BUY
Grant, award, or other acquisition
|
Direct |
8,406
+29.86%
|
-
|
|
Feb 19
2022
|
Franz Peter Barthold VP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
353
-2.17%
|
$6,001
$17.75 P/Share
|
|
Feb 19
2022
|
John E Davis Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
402
-0.49%
|
$6,834
$17.75 P/Share
|
|
Feb 19
2022
|
Matthew A Getz VP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
244
-1.72%
|
$4,148
$17.75 P/Share
|
|
Feb 19
2022
|
Jean F Holloway SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
421
-0.44%
|
$7,157
$17.75 P/Share
|
|
Feb 19
2022
|
Amy Horton VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
256
-0.28%
|
$4,352
$17.75 P/Share
|
|
Feb 19
2022
|
David Ashley Lee Executive VP, COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
526
-0.18%
|
$8,942
$17.75 P/Share
|
|
Feb 19
2022
|
James P Mackin President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,204
-0.92%
|
$54,468
$17.75 P/Share
|
|
Feb 19
2022
|
Dennis B Maier SVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
282
-1.24%
|
$4,794
$17.75 P/Share
|
|
Feb 17
2022
|
Franz Peter Barthold VP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,757
-5.3%
|
$29,869
$17.5 P/Share
|
|
Feb 17
2022
|
Franz Peter Barthold VP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
5,883
+14.98%
|
-
|